Harnessing DNA replication stress to target RBM10 deficiency in lung adenocarcinoma
Authors:
Open Access
- 30 July 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-18
Abstract
The splicing factor RNA-binding motif protein 10 (RBM10) is frequently mutated in lung adenocarcinoma (LUAD) (9-25%). Most RBM10 cancer mutations are loss-of-function, correlating with increased tumorigenesis and limiting the efficacy of current LUAD targeted therapies. Remarkably, therapeutic strategies leveraging RBM10 deficiency remain unexplored. Here, we conduct a CRISPR-Cas9 synthetic lethality (SL) screen and identify ~60 RBM10 SL genes, including WEE1 kinase. WEE1 inhibition sensitizes RBM10-deficient LUAD cells in-vitro and in-vivo. Mechanistically, we identify a splicing-independent role of RBM10 in regulating DNA replication fork progression and replication stress response, which underpins RBM10-WEE1 SL. Additionally, RBM10 interacts with active DNA replication forks, relying on DNA Primase Subunit 1 (PRIM1) that synthesizes Okazaki RNA primers. Functionally, we demonstrate that RBM10 serves as an anchor for recruiting Histone Deacetylase 1 (HDAC1) to facilitate H4K16 deacetylation and R-loop homeostasis to maintain replication fork stability. Collectively, our data reveal a role of RBM10 in fine-tuning DNA replication and provide therapeutic arsenal for targeting RBM10-deficient tumors.Keywords
All Related Versions
Funding Information
- Israel Science Foundation (2511/19, 1283/21)
- Israel Cancer Research Fund (22-110-PG)
- Clore Duffield Foundation
- United States - Israel Binational Science Foundation (2019688, 2021085)
This publication has 105 references indexed in Scilit:
- Frequently mutated genes in predicting the relapse of stage I lung adenocarcinomaClinical and Translational Oncology, 2023
- WEE1 Inhibitor: Clinical DevelopmentCurrent Oncology Reports, 2021
- Alternative splicing in lung cancerBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2019
- Alternative splicing of VEGFA is regulated by RBM10 in endometrial cancerThe Kaohsiung Journal of Medical Sciences, 2019
- First reported adult patient with TARP syndrome: A case reportAmerican Journal of Medical Genetics Part A, 2018
- RBM10: Harmful or helpful‐many factors to considerJournal of Cellular Biochemistry, 2018
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer LiabilitiesCell, 2015
- Integrative analysis revealed the molecular mechanism underlying RBM10‐mediated splicing regulationEMBO Molecular Medicine, 2013
- Long‐term survival in TARP syndrome and confirmation of RBM10 as the disease‐causing geneAmerican Journal of Medical Genetics Part A, 2011
- Massively Parallel Sequencing of Exons on the X Chromosome Identifies RBM10 as the Gene that Causes a Syndromic Form of Cleft PalateThe American Journal of Human Genetics, 2010